The report highlights explosive growth in the use of AI in pharmaceuticals, projecting market value to jump from $3.24 billion in 2024 to over $65 billion by 2033. Key technologies include machine learning and predictive analytics, impacting companies worldwide and enhancing drug discovery and development processes.
Read More:
- š www.businesswire.com